Literature DB >> 8112829

Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.

E Moilanen1, A L Kirkkola, H Kankaanranta, M M Nieminen, H Vapaatalo.   

Abstract

The aim of the present work was to study interactions between the synthesis of platelet-activating factor (PAF) and leukotriene B4 (LTB4) in human polymorphonuclear leukocytes (PMNs) in vitro. PAF, at nanomolar concentrations, stimulated calcium ionophore A23187-activated PMNs to release LTB4 and 5-hydroxyeicosatetraenoic acid (5-HETE). This seems to be a receptor-mediated process as it was blocked by a PAF receptor antagonist WEB 2086 (IC50 6.6 +/- 3.9 microM). Moreover, LTB4 stimulated the formation of PAF in activated PMNs. WEB 2086 did not, however, alter PMN migration towards either LTB4 or the chemotactic peptide FMLP. This suggests that the enhancement of PAF synthesis in response to LTB4 is a concomitant event rather than a mediating process in LTB4-induced chemotactic movement of PMNs. These effects are implicated in the complex network of interactions between inflammatory mediators that results accumulation and activation of PMNs in the exacerbation of inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8112829     DOI: 10.1007/bf00920475

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  26 in total

1.  Tolfenamic acid inhibits leukotriene B4-induced chemotaxis of polymorphonuclear leukocytes in vitro.

Authors:  H Kankaanranta; E Moilanen; H Vapaatalo
Journal:  Inflammation       Date:  1991-04       Impact factor: 4.092

2.  Association of platelet-activating factor with primary acquired cold urticaria.

Authors:  K E Grandel; R S Farr; A A Wanderer; T C Eisenstadt; S I Wasserman
Journal:  N Engl J Med       Date:  1985-08-15       Impact factor: 91.245

3.  Platelet-activating factor (PAF) enhances tumor necrosis factor production by alveolar macrophages. Prevention by PAF receptor antagonists and lipoxygenase inhibitors.

Authors:  C Dubois; E Bissonnette; M Rola-Pleszczynski
Journal:  J Immunol       Date:  1989-08-01       Impact factor: 5.422

Review 4.  Leukotrienes in inflammation.

Authors:  M A Bray
Journal:  Agents Actions       Date:  1986-10

5.  Platelet-activating factor may act as a second messenger in the release of icosanoids and superoxide anions from leukocytes and endothelial cells.

Authors:  A G Stewart; P N Dubbin; T Harris; G J Dusting
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

6.  Involvement of leukotriene B4 and platelet-activating factor in cytokine priming of human polymorphonuclear leucocytes.

Authors:  A G Stewart; T Harris; M De Nichilo; A F Lopez
Journal:  Immunology       Date:  1991-02       Impact factor: 7.397

7.  Pharmacological actions of WEB 2086, a new specific antagonist of platelet activating factor.

Authors:  J Casals-Stenzel; G Muacevic; K H Weber
Journal:  J Pharmacol Exp Ther       Date:  1987-06       Impact factor: 4.030

8.  Platelet-activating factor impairs mucociliary transport and increases plasma leukotriene B4 in man.

Authors:  M M Nieminen; E K Moilanen; M O Koskinen; J I Karvonen; T J Metsä-Ketelä; H Vapaatalo
Journal:  Eur Respir J       Date:  1991-05       Impact factor: 16.671

Review 9.  Recent advances in our understanding of the biochemical interactions between platelet-activating factor and arachidonic acid.

Authors:  F H Chilton; M Cluzel; M Triggiani
Journal:  Lipids       Date:  1991-12       Impact factor: 1.880

10.  Activation and desensitization of platelets by platelet-activating factor (PAF) derived from IgE-sensitized basophils. I. Characteristics of the secretory response.

Authors:  P M Henson
Journal:  J Exp Med       Date:  1976-04-01       Impact factor: 14.307

View more
  3 in total

1.  Inhibition of leukotriene formation and IL-8 release by the paf-receptor antagonist SM-12502.

Authors:  R A Hilger; M Köller; W König
Journal:  Inflammation       Date:  1996-02       Impact factor: 4.092

2.  Leukotriene B(4) induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection.

Authors:  A Talvani; F S Machado; G C Santana; A Klein; L Barcelos; J S Silva; M M Teixeira
Journal:  Infect Immun       Date:  2002-08       Impact factor: 3.441

3.  Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia-reperfusion-mediated tissue injury.

Authors:  Claudia S Bitencourt; Valérie L Bessi; David N Huynh; Liliane Ménard; Julie S Lefebvre; Tania Lévesque; Leila Hamdan; Fanny Sohouhenou; Lucia H Faccioli; Pierre Borgeat; Sylvie Marleau
Journal:  J Cell Mol Med       Date:  2013-11-01       Impact factor: 5.310

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.